Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

    Limited submission

    Supporting biologic-based drug discovery and development for nervous system disorders through preclinical research, Phase I trials, and collaboration with NIH consultants and CROs.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development

    This NIH program supports researchers in developing small-molecule neurotherapeutics by providing funding, expert guidance, and industry resources to advance drug candidates toward clinical testing.

    HHS-NIH11Forecasted Jun 16, 2027Forecasted

    National Centers for Biomedical Imaging and Bioengineering (P41 Clinical Trials Optional)

    This grant funds national centers to develop, share, and train researchers in new biomedical imaging and bioengineering technologies for broad scientific use.

    HHS-NIH11Forecasted Jan 25, 2027Forecasted

    Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

    This grant supports the continued operation of national biobanks for collecting, storing, and distributing cancer clinical trial biospecimens to advance translational cancer research.

    HHS-NIH11Due Feb 11, 2027$19,000,000

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

    Grant supports developing assays to find new therapies for brain and muscle diseases within IGNITE program; doesn't fund clinical trials.

    HHS-NIH11Due Feb 18, 2027$750,000

    Glioblastoma Therapeutics Network (GTN; U19 Clinical Trial Required)

    This grant funds collaborative teams to develop and clinically test new or repurposed drugs that cross the blood-brain barrier to improve adult glioblastoma treatment.

    HHS-NIH11Due Jan 11, 2027$700,000